Ovaryan Hiperstimülasyon Sendromu

Mascarenhas MN, Cheung H, Mathers CD,et al. Measuring infertility in populations: constructing a standard definition for use with demographic and reproductive health surveys. Popul Health Metr. 2012;10(1):17.

Boivin J, Bunting L, Collins JA, et al. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007;22(6):1506-1512.

Rutstein SO, Shah IH. Infecundity, infertility, and childlessness in developing countries. Calverton, MD, Geneva, Switzerland: World Health Organization; 2004.

CDC. Key Statistics from the National Survey of Family Growth. 2017; https://www.cdc.gov/nchs/nsfg/key_statistics/i.htm#infertility. Accessed August 2024

Sunderam S, Kissin DM, Crawford S, et al. Assisted reproductive technology surveillance -- United States, 2010. MMWR Surveill Summ. 2013;62(9):1-24.

Centers for Disease Control and Prevention ASRM, Society for Assisted Reproductive Technology. Assisted Reproductive Technology Fertility Clinic Success Rates Report. 2016. US Dept of Health and Human Services;2016.

Timmons D, Montrief T, Koyfman A, et al. Ovarian hyperstimulation syndrome: A review for emergency clinicians. Am J Emerg Med. 2019 Aug;37(8):1577-1584. doi: 10.1016/j.ajem.2019.05.018. Epub 2019 May 7. PMID: 31097257.

Kumar P, Sait SF, Sharma A, et al. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4(2):70-75.

Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978; 30:255.

Delvgne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002; 8:559.

Papan kolaou EG, Tournaye H, Verpoest W, et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 2005; 20:636.

Binder H, Dittrich R, Einhaus F, et al. Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis. Int J Fertil Womens Med. 2007;52(1):11-26.

Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106(7):1634-1647. doi:10.1016/j.fertnstert.2016.08.048

Luke B, Brown MB, Morbeck DE, et al. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril. 2010;94(4):1399-1404. doi:10.1016/j.fertnstert.2009.05.092

Ashrafi M, Bahmanabadi A, Akhond MR, et al. Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model. Arch Gynecol Obstet. 2015;292(5):1145-1152. doi:10.1007/s00404-015-3723-0

Tummon I, Gavrilova-Jordan L, Allemand MC, et al. Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*. Acta Obstet Gynecol Scand. 2005;84(7):611-616. doi:10.1111/j.0001-6349.2005.00788.x

Lee TH, Liu CH, Huang CC, et al. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23(1):160-167. doi:10.1093/humrep/dem254

Jayaprakasan K, Chan Y, Islam R, et al. Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women. Fertil Steril. 2012;98(3):657-663. doi:10.1016/j.fertnstert.2012.05.042

Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet. 2011;28(12):1197-1203. doi:10.1007/s10815-011-9627-4

Jayaprakasan K, Herbert M, Moody E, Stewart JA, Murdoch AP. Estimating the risks of ovarian hyperstimulation syndrome (OHSS): implications for egg donation for research. Hum Fertil (Camb). 2007;10(3):183-187. doi:10.1080/14647270601021743

Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8(6):559-577. doi:10.1093/humupd/8.6.559

Blumenfeld Z. The Ovarian Hyperstimulation Syndrome. Vitam Horm. 2018;107:423-451. doi:10.1016/bs.vh.2018.01.018

Mascarenhas MN, Cheung H, Mathers CD,et al. Measuring infertility in populations: constructing a standard definition for use with demographic and reproductive health surveys. Popul Health Metr. 2012;10(1):17.

Boivin J, Bunting L, Collins JA, et al. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007;22(6):1506-1512.

Rutstein SO, Shah IH. Infecundity, infertility, and childlessness in developing countries. Calverton, MD, Geneva, Switzerland: World Health Organization; 2004.

CDC. Key Statistics from the National Survey of Family Growth. 2017; https://www.cdc.gov/nchs/nsfg/key_statistics/i.htm#infertility. Accessed August 2024

Sunderam S, Kissin DM, Crawford S, et al. Assisted reproductive technology surveillance -- United States, 2010. MMWR Surveill Summ. 2013;62(9):1-24.

Centers for Disease Control and Prevention ASRM, Society for Assisted Reproductive Technology. Assisted Reproductive Technology Fertility Clinic Success Rates Report. 2016. US Dept of Health and Human Services;2016.

Timmons D, Montrief T, Koyfman A, et al. Ovarian hyperstimulation syndrome: A review for emergency clinicians. Am J Emerg Med. 2019 Aug;37(8):1577-1584. doi: 10.1016/j.ajem.2019.05.018. Epub 2019 May 7. PMID: 31097257.

Kumar P, Sait SF, Sharma A, et al. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4(2):70-75.

Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978; 30:255.

Delvgne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002; 8:559.

Papan kolaou EG, Tournaye H, Verpoest W, et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 2005; 20:636.

Binder H, Dittrich R, Einhaus F, et al. Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis. Int J Fertil Womens Med. 2007;52(1):11-26.

Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106(7):1634-1647. doi:10.1016/j.fertnstert.2016.08.048

Luke B, Brown MB, Morbeck DE, et al. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril. 2010;94(4):1399-1404. doi:10.1016/j.fertnstert.2009.05.092

Ashrafi M, Bahmanabadi A, Akhond MR, et al. Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model. Arch Gynecol Obstet. 2015;292(5):1145-1152. doi:10.1007/s00404-015-3723-0

Tummon I, Gavrilova-Jordan L, Allemand MC, et al. Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*. Acta Obstet Gynecol Scand. 2005;84(7):611-616. doi:10.1111/j.0001-6349.2005.00788.x

Lee TH, Liu CH, Huang CC, et al. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23(1):160-167. doi:10.1093/humrep/dem254

Jayaprakasan K, Chan Y, Islam R, et al. Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women. Fertil Steril. 2012;98(3):657-663. doi:10.1016/j.fertnstert.2012.05.042

Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet. 2011;28(12):1197-1203. doi:10.1007/s10815-011-9627-4

Jayaprakasan K, Herbert M, Moody E, Stewart JA, Murdoch AP. Estimating the risks of ovarian hyperstimulation syndrome (OHSS): implications for egg donation for research. Hum Fertil (Camb). 2007;10(3):183-187. doi:10.1080/14647270601021743

Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8(6):559-577. doi:10.1093/humupd/8.6.559

Blumenfeld Z. The Ovarian Hyperstimulation Syndrome. Vitam Horm. 2018;107:423-451. doi:10.1016/bs.vh.2018.01.018